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Sex-related differences in the efficacy of dexamethasone pretreatment
for postoperative analgesia in patients undergoing laparoscopic
cholecystectomy: a randomized controlled study
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Background/aim: Sex-related differences in response to pain have become a topic of increasing interest. However, sex-related differences
in the efficacy of dexamethasone for postoperative analgesia have not been previously addressed.
Materials and methods: The study included 196 men and 196 women, aged between 18 and 45 years, who were scheduled for laparoscopic
cholecystectomy. The patients were randomly allocated into dexamethasone (M/F: 98/98) and control (normal saline; M/F: 98/98)
groups. Patients in the study group received intravenous dexamethasone at 0.1 mg/kg (dexamethasone group) 1 h before induction
of anesthesia. Patients in the control group received normal saline. Changes in cumulative morphine-containing, patient-controlled
analgesia consumption in both sexes, pain intensity using a visual analog scale 24 h after surgery, mean morphine consumption adjusted
for body weight, and incidence of postoperative nausea or vomiting were measured.
Results: Women in both groups had significantly higher pain scores at 1 and 6 h postoperatively, higher levels of patient-controlled
analgesia and mean morphine consumption, and more postoperative nausea and vomiting (P < 0.05). These effects were less severe in
the dexamethasone group.
Conclusion: The results suggest that women are less responsive than men to dexamethasone for postoperative analgesia and experience
higher levels of postoperative pain.
Key words: Gonadal hormones, pain, sex

1. Introduction
Sex-related differences in pain response and response to
analgesics have been increasingly studied in recent years.
Research has focused on a number of physiopsychosocial
factors including gonadal hormones, endogenous opioid
function, genetic factors, pain coping and catastrophizing,
and gender roles, which may contribute to these differences
(1,2). Some authors have reported that women experience
greater postoperative pain severity or diminished pain
tolerance (3,4), while others have found no sex-related
differences (5,6). Some evidence has supported sex-related
differences in response to certain analgesic drugs, but
these findings were inconsistent (3–6).
The antiinflammatory effects of dexamethasone are
now known to contribute to pain relief and amelioration
of nausea and vomiting (7,8). However, it has not yet
been examined whether the efficacy of dexamethasone
* Correspondence: gooddr21@naver.com
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for reducing pain intensity and opioid consumption is
affected by sex or not.
This aim of this study was to investigate sex-related
differences in the effects of dexamethasone pretreatment
on pain intensity and morphine consumption in patients
undergoing laparoscopic cholecystectomy.
2. Materials and methods
Ethical approval for this study (Registration No. 3658)
was provided by the institutional review board of a
university hospital in March 2014. Written informed
consent was obtained from each participant. The study
was performed at the university hospital from April 2014
to August 2016. A total of 392 patients aged between 18
and 45 years and from Class I or II of the American Society
of Anesthesiologists (ASA) who were scheduled for
laparoscopic cholecystectomy were included. Patients with
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hepatic and renal insufficiency, history of corticosteroid
hypersensitivity, previous gastric ulcer, diabetes mellitus,
and those receiving corticosteroids, immunosuppressive
drugs, chronic opioids, or other analgesics were excluded.
Patients were randomly allocated to the treatment
group (M/F: 98/98) and the control group (M/F: 98/98)
using sealed envelopes.
On the day before surgery, all patients were taught
how to use the visual analog scale (VAS) and the patientcontrolled analgesia (PCA) device, and they were
instructed to deliver analgesia on their own whenever they
felt pain.
All patients were premedicated with intramuscular
midazolam (2–3 mg) before arriving to the operating room.
One hour before the induction of anesthesia, patients
in the dexamethasone group received 0.1 mg/kg (5 mg/
mL) intravenous (IV) dexamethasone, whereas those in
the control group received IV normal saline. Monitoring
including pulse oximetry, automated blood pressure (BP)
cuff, electrocardiogram (ECG), and end-tidal CO2 (ETCO2)
with arterial and urinary catheterization was performed.
Tympanic temperature was measured immediately before
induction of anesthesia and again immediately before
extubation.
Anesthesia induction began with a slow (30–60 s)
IV bolus dose of remifentanil (1 µg/kg), followed by
propofol (1–2 mg/kg). Tracheal intubation was facilitated
with rocuronium (0.9 mg/kg) and a fixed dose of
remifentanil (0.1 µg/kg per minute) was infused in both
groups. Anesthesia was maintained with a desflurane
50% oxygen/air mixture. Desflurane administration
was started at an end-tidal concentration of 1 minimum
alveolar concentration (MAC), and the concentration was
adjusted by a 1% stepwise titration according to acceptable
hemodynamic limits (mean arterial blood pressure
between −20% and +20% and heart rate between −20%
and +20%) and to a target bispectral index (BIS) between
40 and 60.
Upon completion of surgery, the residual neuromuscular
blockade was antagonized with pyridostigmine (0.2 mg/
kg) and glycopyrrolate (0.008 mg/kg) when the train-offour (TOF) ratio had returned to 25%. The patients were
extubated when BIS values reached 80 and spontaneous
breathing was resumed.
The PCA mixture contained morphine (60 mg),
ketorolac (150 mg), and ramosetron (0.6 mg) in a total
volume of 100 mL of saline. The device was set to deliver
a basal infusion of 2 mL/h with bolus doses of 0.5 mL and
a 15-min lockout period. Postoperative pain intensity was
documented using a 100-mm linear VAS that consisted of
a straight line, with the left end of the line representing
no pain (0) and the right end of the line representing the
worst pain (100). During postanesthesia recovery, patients

with VAS scores of ≥40 received 30 mg of IV ketorolac with
an additional dose of 15 mg, if needed. Postoperative VAS
score on exertion was measured at 1, 6, 12, and 24 h from
the time of initial arrival at the postanesthesia care unit.
The primary outcome was changes in cumulative
morphine-containing PCA consumption in both sexes.
The secondary measures were VAS scores on exertion at 1,
6, 12, and 24 h after surgery; mean morphine consumption
adjusted by body weight; time to first postoperative
analgesic requirement; and any episode of postoperative
nausea or vomiting (PONV). PONV was treated with IV
ondansetron (4 mg).
2.1. Statistical analysis
A preliminary investigation showed that the means of
cumulative PCA morphine consumption in women
and men were 63.85 and 61.95 mL, respectively, with a
standard deviation (SD) of 6.17 and 6.58. Considering
power of 80% and an α-coefficient of 0.05 for cumulative
PAC consumption of morphine in women compared to
men in each group, the sample size was calculated as 178
samples for each group. Assuming a 10% dropout rate, the
final sample size was determined to be 196 patients per
group (98 men and 98 women). The statistical analysis was
performed using SPSS 18.0 (SPSS Inc., Chicago, IL, USA).
The results are presented as mean ± SD or as number
of patients (%). Means between groups and between
women and men within groups were conducted using the
independent t-test, and categorical data were evaluated
using chi-square tests. Significance was defined as P < 0.05.
3. Results
Twelve of the total 392 patients that were included in the
study were withdrawn from the final analysis because
of conversion to open surgery or reexploration for
postoperative bleeding. Of the 380 remaining patients,
191 were in the control group and 189 were in the
dexamethasone group.
There were no significant differences between two
groups with respect to age, sex, weight, and duration of
surgery (Table 1).
Compared to the controls, patients in the
dexamethasone group had lower cumulative PCA
consumption, mean morphine consumption adjusted for
body weight, and rescue analgesia (ketorolac) requirements
(P < 0.05). Additionally, patients in the dexamethasone
group had lower VAS pain scores on exertion at 1, 6, and
12 h postoperatively; a lower incidence of PONV and
antiemetic (ondansetron) required; and a significantly
longer time to first postoperative analgesic dose than those
in the control group (P < 0.05) (Table 1).
On comparison by sex, women in both the
dexamethasone group and the control group had
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Table 1. Patient characteristics.
Control group
(n = 191)

Dexamethasone group
(n = 189)

Age (years)

40.9 ± 2.4

40.3 ± 4.0

Weight (kg)

63.5 ± 6.9

64.4 ± 6.7

Sex (male/female)

97/94

94/95

Time of surgery (min)

58.0 ± 8.6

58.0 ± 8.8

Time to first postoperative analgesic administration (min)

34.9 ± 8.9

39.1 ± 8.6*

Cumulative PCA consumption (mL)

64.4 ± 50.3

61.0 ± 6.0*

Mean morphine consumption (mg/kg)

0.61 ± 0.08

0.58 ± 0.08*

VAS, 1 h

46.8 ± 9.7

42.5 ± 8.4*

VAS, 6 h

41.6 ± 8.0

36.4 ± 7.8*

VAS, 12 h

31.4 ± 7.1

28.0 ± 5.9*

VAS, 24 h

22.9 ± 6.7

22.6 ± 4.6

Ketorolac consumption (mg)

37.6 ± 7.7

35.2 ± 7.1*

Postoperative nausea or vomiting

68 (35.6)

45 (23.8)*

Antiemetic requirement

62 (32.5)

69(20.6)*

Pain intensity with effort

Values are expressed as mean ± SD or number (%) of patients. VAS: Visual analog scale, PCA: patient-controlled analgesia. *: P < 0.05
vs. control group.

significantly higher VAS pain scores with exertion at 1
and 6 h, and greater mean morphine consumption with a
higher incidence of PONV and antiemetic (ondansetron)
required during 24 h (P < 0.05). Women in both groups had
shorter time to first postoperative analgesic requirement
(P < 0.05). Men in the control group had greater
cumulative PCA consumption during 24 h after surgery
than women, but the difference was not significant. In
the dexamethasone group, women had higher cumulative
consumption of PCA in 24 h compared to men (P < 0.05)
(Table 2).
4. Discussion
The strong antiinflammatory properties of dexamethasone
have been associated with its efficacy when used
for postoperative analgesia. Although the analgesic
mechanism of dexamethasone has not been fully
elucidated, it appears that a decrease in cyclooxygenase
and lipoxygenase production, via inhibition of peripheral
phospholipase, plays a main role (7–9).
Several recent investigations have reported the
potential analgesic benefit of dexamethasone. However,
they showed inconsistent findings, which resulted from
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variability in the type of surgery, dexamethasone dose
and timing, anesthetic regimen, and type of postoperative
rescue analgesic (7). However, these previous studies have
not considered sex-related differences in dexamethasone
efficacy.
Our study has shown that women undergoing
laparoscopic cholecystectomy had higher postoperative
VAS pain scores with exertion levels of pain, greater
mean morphine consumption when corrected for body
weight, and shorter time to first postoperative analgesic
dose administration than men. Sex-related differences in
pain response and opioid susceptibility remain a matter of
debate. Some studies have reported that men have higher
pain thresholds and greater pain tolerance for all types of
noxious stimuli than women (3,4). However, other studies
have shown no significant differences in pain scores
between men and women (5,6). Several other studies
have consistently supported the existence of sex-based
differences in pain modulation between men and women.
Therefore, sex could be an important consideration in
providing optimum analgesia (1–4,10).
Women in both groups consumed a proportionally
larger amount of morphine when adjusted for body
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Table 2. Comparison of pain scores, morphine consumption, and postoperative nausea or vomiting in men and women.
Control group

Dexamethasone group

Men
(n = 97)

Women
(n = 94)

Men
(n = 94)

Women
(n = 95)

Time to first postoperative analgesic requirement (min)

36.0 ± 9.5

33.7 ± 8.2*

41.6 ± 7.7

36.5 ± 8.6*

Cumulative PCA consumption (mL)

64.8 ± 4.8

64.0 ± 5.3

60.2 ± 6.2

61.9 ± 5.6*

Mean morphine consumption (mg/kg)

0.57 ± 0.06

0.66 ± 0.07*

0.53 ± 0.07

0.62 ± 0.07*

VAS, 1 h

45.3 ± 9.6

48.4 ± 9.5*

40.1 ± 8.7

44.8 ± 7.4*

VAS, 6 h

40.4 ± 6.9

42.8 ± 8.8*

33.7 ± 7.0

39.1 ± 7.6*

VAS, 12 h

31.3 ± 6.6

31.5 ± 7.8

27.7 ± 5.4

28.3 ± 6.5

VAS, 24 h

22.9 ± 6.1

22.9 ± 7.3

22.6 ± 4.6

22.6 ± 4.7

Postoperative nausea or vomiting for 24 h

23 (23.8)

45 (48)*

15 (16.0)

30 (31.6)*

Antiemetic required

20 (21.6)

41 (43.6)*

10 (10.6)

29 (30.5)*

Pain intensity with effort

Values are expressed as mean ± SD or number (%) of patients. VAS: Visual analog scale (0 to 100), PCA: patient controlled analgesia.
*: P < 0.05 vs. men.

weight. This is in line with most recent studies, which
have reported that the potency and efficacy of morphine is
greater in men than in women over a variety of nociceptive
modalities (11,16). When studies are performed using
PCA in a postoperative setting, sex-based differences in
pain response and analgesic efficacy may be confounded by
psychological factors or personality traits, or particularly
by opioid side effects such as PONV, which may affect the
frequency of PCA administration and the degree of pain
intensity and pain relief.
In our results, sex-related differences remained even
after correcting for body weight, suggesting that the
differences may be due to gonadal hormones such as
estrogen and testosterone, in addition to subjective or
psychosocial factors that may affect pain behaviors (1).
The findings suggesting diminished analgesic efficacy
of dexamethasone in women in our study may further
support a role for gonadal hormones in analgesia
response. It has been found that dexamethasone acts
directly on the pituitary gland to suppress the action
of estradiol and lowers circulating estrogens (17,18).
Gonadal hormones are associated with modulating
pain intensity (19). A decrease in pain threshold and an
increase in morphine consumption has been found in
women with menstrual cycles, notably during the luteal
phase (19,20). Our study also showed that the potential
postoperative antiemetic effects of dexamethasone in
women were greater than in men (reduction rate of PONV
16.4% vs. 7.8%). The apparent sex-based difference in the

efficacy of dexamethasone against PONV may also be
related to gonadal hormones. Estradiol may sensitize the
chemoreceptor trigger zone or the vomiting center of the
brain. Taken together, the interaction between gonadal
hormones and dexamethasone may exist in pain control
and morphine sparing (20–22).
A limitation of this study was that we did not consider
the hormonal state of the women or the stages of their
menstrual cycles. Thus, this could be another possible
uncontrolled confounding factor of the difference in
the results. Another possibility is that women simply
reported their pain more readily, whereas men were
underreporting.
In conclusion, the mechanistic basis for sex-related
differences in pain response and analgesic efficacy is not
entirely understood; however, sex hormones are thought
to be an influencing factor. An improved understanding
of the mechanisms underlying sex-related differences
in pain perception and response to analgesic drugs
should permit improved pain management strategies for
postoperative patients. Although the observed sex-related
differences in opioid effects may be clinically relevant, the
lack of knowledge about other factors involved in the large
variability of patient opioid analgesic sensitivity should
compel practitioners to customize their dosing regimens
based on individual requirements.
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